Boston Scientific (BSX) Return on Capital Employed (2009 - 2026)
Boston Scientific (BSX) posted quarterly Return on Capital Employed of 10.83% for Q2 2026, up 200.0% year-over-year from 3.61% in Q2 2025, and up 12.56% on a QoQ basis from 9.62% in Q1 2026.
Boston Scientific (BSX) Return on Capital Employed (2009 - 2026) Analysis & Trends
Boston Scientific has reported Return on Capital Employed for 18 years, with the latest figure at 10.83% in Q2 2026.
- Return on Capital Employed for Q2 2026 came in at 10.83%, up 200.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 10.83% (up 200.0% YoY), and the FY2025 annual result was 10.01%, up 158.0% from the prior year.
- Return on Capital Employed advanced to 10.83% in Q2 2026, from 9.62% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 10.83% in Q2 2026 and troughed at 4.62% in Q1 2022.
- A 5-year average of 7.59% and a median of 7.91% in 2023 frame the typical range for Return on Capital Employed.
- The widest annual swing landed in 2022, when Return on Capital Employed jumped 410 bps; it then grew 15 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 5.81% in 2022, then surged by 36 bps to 7.9% in 2023, then gained by 2 bps to 8.05% in 2024, then grew by 19 bps to 9.57% in 2025, then advanced by 13 bps to 10.83% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 10.83% in Q2 2026, 9.62% in Q1 2026, and 9.57% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 12.08% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 6.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.83% |
| Mar 31, 2026 | 9.62% |
| Dec 31, 2025 | 9.57% |
| Sep 30, 2025 | 9.41% |
| Jun 30, 2025 | 8.83% |
| Mar 31, 2025 | 8.21% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | 7.93% |
| Jun 30, 2024 | 7.89% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | 7.90% |
| Sep 30, 2023 | 7.39% |
| Jun 30, 2023 | 6.37% |
| Mar 31, 2023 | 6.07% |
| Dec 31, 2022 | 5.81% |
| Sep 30, 2022 | 5.00% |
| Jun 30, 2022 | 5.13% |
| Mar 31, 2022 | 4.62% |
| Dec 31, 2021 | 4.32% |
| Sep 30, 2021 | 3.89% |